Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ABCB1 | P08183 | 2/20 | 0.73 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.70 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.70 |
| ▸ | MEN1 | O00255 | 3/20 | 0.70 |
| ▸ | MAPT | P10636 | 3/20 | 0.70 |
| ▸ | RECQL | P46063 | 3/20 | 0.70 |
| ▸ | AMY1A | P0DUB6 | 3/20 | 0.70 |
| ▸ | POLB | P06746 | 2/20 | 0.70 |
| ▸ | GAA | P10253 | 2/20 | 0.70 |
| ▸ | THRB | P10828 | 2/20 | 0.70 |
| ▸ | BLM | P54132 | 2/20 | 0.70 |
| ▸ | NPC1 | O15118 | 1/20 | 0.70 |
| ▸ | APEX1 | P27695 | 1/20 | 0.70 |
| ▸ | CASP6 | P55212 | 1/20 | 0.70 |
| ▸ | GFER | P55789 | 1/20 | 0.70 |
| ▸ | POLH | Q9Y253 | 4/20 | 0.64 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.64 |
| ▸ | ALOX5 | P09917 | 2/20 | 0.64 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.64 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.64 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20718935 | 0.88 | ABCB1 (0.71) | ABCB1KMT2AKDM4EMEN1MAPT | |
| SCHEMBL515131 | 0.87 | ABCB1 (0.80) | ABCB1KMT2AKDM4EMEN1MAPT | |
| 6-Hydroxyluteolin SCHEMBL29929561 | 0.87 | KMT2A (0.76) | ABCB1KMT2AKDM4EMEN1MAPT | |
| 6-Hydroxyluteolin SCHEMBL29887622 | 0.87 | KMT2A (0.76) | ABCB1KMT2AKDM4EMEN1MAPT | |
| 6-Hydroxyluteolin SCHEMBL30217544 | 0.87 | KMT2A (0.76) | ABCB1KMT2AKDM4EMEN1MAPT | |
| 6-Hydroxyluteolin SCHEMBL1155724 | 0.87 | KMT2A (0.76) | ABCB1KMT2AKDM4EMEN1MAPT | |
| SCHEMBL6245328 | 0.84 | ABCB1 (1.00) | ABCB1KMT2AKDM4EMEN1MAPT | |
| SCHEMBL16088300 | 0.83 | HDAC6 (0.78) | ABCB1KMT2AKDM4EMEN1MAPT | |
| Eupafolin SCHEMBL29929325 | 0.83 | MEN1 (1.00) | KMT2AKDM4EMEN1MAPTRECQL | |
| Eupafolin SCHEMBL29915043 | 0.83 | MEN1 (1.00) | KMT2AKDM4EMEN1MAPTRECQL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-104529975-B | Corm Eleocharitis skin extracts the method for 6-methyl luteolin | 贺州学院 | 2016-07-06 | — | — | CN | claimed |
| CN-104529975-A | Method for extracting 6-methylluteolin from eleocharis tuberose peels | UNIV HEZHOU | 2015-04-22 | — | — | CN | claimed |
| CN-119335102-A | Method for detecting traditional Chinese medicine source components in pinecone alcohol extract | 大理大学 | 2025-01-21 | — | — | CN | disclosed |
| US-9415034-B2 | Inhibitors and enhancers of uridine diphosphate-glucuronosyltransferase 2B (UGT2B) | NATIONAL DEFENSE MEDICAL CENTER (TW) | 2016-08-16 | — | — | US | disclosed |
| CN-104529975-B | Corm Eleocharitis skin extracts the method for 6-methyl luteolin | 贺州学院 | 2016-07-06 | — | — | CN | disclosed |
| CN-104529975-B | Corm Eleocharitis skin extracts the method for 6-methyl luteolin | 贺州学院 | 2016-07-06 | — | — | CN | disclosed |
| CN-104529975-B | Corm Eleocharitis skin extracts the method for 6-methyl luteolin | 贺州学院 | 2016-07-06 | — | — | CN | disclosed |
| US-20160184298-A1 | INHIBITORS AND ENHANCERS OF URIDINE DIPHOSPHATE-GLUCURONOSYLTRANSFERASE 2B (UGT2B) | NAT DEFENSE MEDICAL CT (TW) | 2016-06-30 | — | — | US | disclosed |
| US-9265808-B2 | Compositions for alleviating inflammation and oxidative stress in a mammal | LIFELINE NUTRACEUTICALS CORPORATION (US) | 2016-02-23 | — | — | US | disclosed |
| US-20150283193-A9 | Compositions for Alleviating Inflammation and Oxidative Stress in a Mammal | LIFELINE NUTRACEUTICALS (US) | 2015-10-08 | — | — | US | disclosed |
| CN-104529975-A | Method for extracting 6-methylluteolin from eleocharis tuberose peels | UNIV HEZHOU | 2015-04-22 | — | — | CN | disclosed |
| CN-1658757-A | Antihelminthic anthraquinones and method of use thereof | UNIV MICHIGAN (US) | 2005-08-24 | — | — | CN | disclosed |
| US-6903076-B2 | Antihelminthic anthraquinones and method of use thereof | BOARD OF TRUSTEES OF MICHIGAN STATE UNIVERSITY (US) | 2005-06-07 | — | — | US | disclosed |
| US-6838443-B2 | Antihelminthic anthraquinones and method of use thereof | BOARD OF TRUSTEES OF MICHIGAN STATE UNIVERSITY (US) | 2005-01-04 | — | — | US | disclosed |
| US-6800615-B2 | PARASITICIDES, NEMATOCIDES | BOARD OF TRUSTEES OF MICHIGAN STATE UNIVERSITY | 2004-10-05 | — | — | US | disclosed |
| US-20040152645-A1 | Antihelminthic anthraquinones and method of use thereof | BOARD OF TRUSTEES OF MICHIGAN STATE UNIVERSITY | 2004-08-05 | — | — | US | disclosed |
| US-20040116361-A1 | Antihelminthic anthraquinones and method of use thereof | BOARD OF TRUSTEES OF MICHIGAN STATE UNIVERSITY | 2004-06-17 | — | — | US | disclosed |
| US-20040106686-A1 | Antihelminthic anthraquinones and method of use thereof | BOARD OF TRUSTEES OF MICHIGAN STATE UNIVERSITY | 2004-06-03 | — | — | US | disclosed |
| US-20030229032-A1 | Antihelminthic anthraquinones and method of use thereof | BOARD OF TRUSTEES OF MICHIGAN STATE UNIVERSITY | 2003-12-11 | — | — | US | disclosed |
| WO-2003089577-A2 | ANTIHELMINTHIC ANTHRAQUINONES AND METHOD OF USE THEREOF | MICHIGAN STATE UNIVERSITY (US) | 2003-10-30 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030229032-A1 | Antihelminthic anthraquinones and method of use thereof | HRH2, HRH3, HRH1 | ABCB1 1577/4885KMT2A 703/4885KDM4E 1098/4885 |
| US-20040152645-A1 | Antihelminthic anthraquinones and method of use thereof | HRH2, HRH3, HRH1 | ABCB1 1577/4885KMT2A 703/4885KDM4E 1098/4885 |
| US-20160184298-A1 | INHIBITORS AND ENHANCERS OF URIDINE DIPHOSPHATE-GLUCURONOSYLTRANSFERASE 2B (UGT2B) | UGT2B7, UGT2B17, UGT1A10 | ABCB1 18/4885KMT2A 4826/4885KDM4E 4425/4885 |
| US-20150283193-A9 | Compositions for Alleviating Inflammation and Oxidative Stress in a Mammal | GSTO1, GSTK1, GSTP1 | ABCB1 2413/4885KMT2A 658/4885KDM4E 2166/4885 |
| US-20040106686-A1 | Antihelminthic anthraquinones and method of use thereof | HRH2, HRH3, HRH1 | ABCB1 1577/4885KMT2A 703/4885KDM4E 1098/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.